One of the stocks that may come into focus this morning among investors in light of the latest developments is Emergent Health Corp (OTCMKTS:EMGE). Yesterday the company was in the news after it announced that it had signed a letter of intent with MeetHook LLC through its subsidiary unit PharmaZu.
Trading Data
On Tuesday, EMGE stock fell 1.75% to $0.0056 with 782k shares, compared to its average volume of 2.28 million shares. The stock moved within a range of $0.0044 – 0.0056 after opening trade at $0.0056.
Emergent Executes Letter of Intent to Partner with MeetHook to Jointly Develop “Pharmazu Virtual Visits,” a Platform for Pet Owners To Have 24/7 Access to Qualified Veterinary Specialists for The USD 119.6 Million Global Veterinary Telehealth Marketplace
The two entities are going to be involved in the development of PharmaZu Virtual Visits, a platform that is going to provide pet owners with access to veterinary specialists around the clock. The global veterinary telehealth marketplace is worth as much as $119.6 billion and hence, the latest move from Emergent Health could actually prove to be a significant move in the long term.
That being said, it is also important to keep in mind that there are currently a number of platforms that provide the same service. However, the collaboration with MeetHook is going to help with providing pet owners with a wide range of choices with regard to the specialists that they choose to contact.
In addition to that, there is also going to be a wide range of features that are going to help pet owners who choose to use the platform.
Key Quote
MeetHook Founder & CEO Anthony Citrinite stated, “The Meethook RevShare Video On Demand Platform can be plugged into related companies and products such as PharmaZu, giving pet owners 24/7 access to qualified veterinary specialists and provide On Demand content including Professionals in their field, Doctors and Influencers with a Healthy tip or Workout routine that PharmaZu’s pet owners can watch.
Technical Data
EMGE stock is trading below the 20-Day and 50-Day Moving averages of $0.0062 and $0.0074 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.0109.
